Mechanisms of gender-related outcome differences after carotid endarterectomy

J Vasc Surg. 2010 Oct;52(4):1062-71, 1071.e1-6. doi: 10.1016/j.jvs.2010.03.068. Epub 2010 Jun 22.

Abstract

Objective: Large randomized trials have confirmed a difference in outcome after carotid endarterectomy (CEA) between men and women. In this review, we aimed to provide an overview of the gender-specific characteristics causing these perioperative and long-term outcome differences between men and women after CEA.

Methods: A systematic search strategy with the synonyms of 'gender' and 'carotid endarterectomy' was conducted from PubMed and EMBASE databases. Only 11 relevant studies specifically discussing gender-specific related characteristics and their influence on outcome after CEA could be identified.

Results: Due to the limited number of included studies, pooling of findings was impossible, and results are presented in a descriptive manner. Each included study described only one possible gender-specific factor. Differences in carotid artery diameter, sex hormones, sensitivity for antiplatelet therapy, plaque morphology, occurrence of microembolic signals, and restenosis rate have all been suggested as gender-specific characteristics influencing outcome after CEA.

Conclusion: Higher embolic potential in women and relatively stable female plaque morphology are the best-described factors influencing the difference in outcomes between men and women. However, the overall evidence for outcome differences by gender-specific characteristics in the literature is limited.

Publication types

  • Review

MeSH terms

  • Carotid Artery Diseases / pathology
  • Carotid Artery Diseases / surgery*
  • Endarterectomy, Carotid / adverse effects*
  • Estrogen Replacement Therapy / adverse effects
  • Evidence-Based Medicine
  • Female
  • Health Status Disparities*
  • Humans
  • Male
  • Platelet Aggregation Inhibitors / therapeutic use
  • Recurrence
  • Risk Assessment
  • Risk Factors
  • Sex Factors
  • Stroke / etiology
  • Thromboembolism / etiology
  • Time Factors
  • Treatment Outcome

Substances

  • Platelet Aggregation Inhibitors